Rivastigmine is a cholinesterase inhibitor which improves cognitive function and is currently being used in patients with mild to moderate Parkinson's and Alzheimer's dementia. This drug can be given orally or topically, as transdermal patch. The latter form is currently used for most excellent compliance and few side effects. The most common cutaneous side effects are irritative dermatitis. We report the second case of active sensitization by the rivastigmine-patch in a patient suffering from Alzheimer's dementia. (copyright) 2011 T. Grieco et al.
CITATION STYLE
T., G., M., R., V., F., I., D. M., P., P., & S., C. (2011). An atypical cutaneous reaction to rivastigmine transdermal patch. Journal of Allergy. Retrieved from http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L364545930
Mendeley helps you to discover research relevant for your work.